Concepedia

Petr Kopsa

PK

Statistics

Publications

1

Citations

73

H-Index

1

Active since

2005

Affiliations

Novartis (Switzerland)(Current)

Petr Kopsa is an author at Novartis (Switzerland) specializing in disease activity measurement, osteoarthritis management, and analgesia.

Publications per year

2005–2005

1

Publications

1

Efficacy and tolerability of lumiracoxib 100 mg once daily in knee osteoarthritis: a 13-week, randomized, double-blind study vs. placebo and celecoxib

R. Lehmann, Marek Brzosko, Petr Kopsa et al. · Current Medical Research and Opinion · 2005 · 73 citations

, , +15

1–1 of 1